Universe Pharmaceuticals Inc
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Universe Pharmaceuticals Inc now
Current reporting with the operating signal separated from the noise.
Universe Pharmaceuticals INC.: Universe Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical Patent Portfolio
The story matters when it changes Universe Pharmaceuticals Inc’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Universe Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical Patent Portfolio
The story matters when it changes Universe Pharmaceuticals Inc’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Universe Pharmaceuticals INC Announces Share Consolidation
Investors are testing whether Universe Pharmaceuticals Inc’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Universe Pharmaceuticals INC Announces $15 Million Registered Direct Offering
The story matters when it changes Universe Pharmaceuticals Inc’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Universe Pharmaceuticals INC Announces Inclusion of Six Products into the First Edition of Catalogue of Medicine for Patients Infected with COVID-19
The development tests whether Universe Pharmaceuticals Inc can turn product investment into adoption, revenue and durable advantage.
Watch next: confirmation in a company filing, official release or regulator record.Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2022
The story matters when it changes Universe Pharmaceuticals Inc’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Universe Pharmaceuticals INC Enters into Letter of Intent for Strategic Cooperation with Kitanihon Pharmaceutical Co., Ltd.
The story matters when it changes Universe Pharmaceuticals Inc’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest UPC filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Universe Pharmaceuticals Inc, quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →